Molecular Partners Ag (MOLN) Revenue (2020 - 2024)

Molecular Partners Ag (MOLN) has reported Revenue for 5 consecutive years, with $5.7 million the latest figure, recorded in Q4 2024.

• On a quarterly basis, Revenue fell 28.07% year-over-year to $5.7 million in Q4 2024; TTM through Jun 2026 was $5.7 million, a 23.12% decrease from a year earlier, with the FY2024 full-year figure at $5.7 million, down 27.47% from the prior year.
• Revenue was $5.7 million for Q4 2024 at Molecular Partners Ag, up from $786.02 in the prior quarter.
• Over five years, Revenue peaked at $196.6 million in Q4 2022 and troughed at $307.44 in Q3 2020.
• A 5-year average of $13.9 million and a median of $324321.9 in 2022 frame the typical range for Revenue.
• Across the five-year window, Revenue soared 17213.3% in 2022 and slumped 98.24% in 2023, its largest moves.
• Over 5 years, Revenue stood at $10.3 million in 2020, then grew by 2.35% to $10.6 million in 2021, then soared by 1760.19% to $196.6 million in 2022, then tumbled by 95.97% to $7.9 million in 2023, then declined by 28.07% to $5.7 million in 2024.
• The last three Revenue figures came in at $5.7 million (Q4 2024), $786.02 (Q3 2024), and $1.7 million (Q2 2024), per Business Quant data.